jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Oct. 05, 2022

May. 22, 2023

jRCT1030220360

MDS-NMS TRANSLATION PROGRAM FOR NON-ENGLISH OFFICIAL VERSIONS

MDS-NMS TRANSLATION PROGRAM

Genko Oyama

Neurology, Juntendo University

2-1-1 Hongo, Bunkyo-ku, Tokyo

+81-3-3813-3111

g_oyama@juntendo.ac.jp

Yoshiyuki Matsuzaki

Mebix Inc.

10F. Toranomon 33 Mori Building 3-8-21 Toranomon, Minato-ku, Tokyo

+81-3-4362-4500

MDS-NMS_validation-study@mebix.co.jp

Complete

Oct. 05, 2022

June. 08, 2022
300

Observational

Patients whose native language is Japanese

Patients diagnosed with Parkinson's disease according to the International Parkinson and Movement Disorder Society's Parkinson's Disease Diagnostic Criteria 2015

Patients who are able to obtain written consent for participation in the study of their own free will after receiving a thorough explanation of their participation in the study.

Patients between the ages of 20 and 79 years old

Any gender

Patients with serious underlying diseases or complications that make it difficult for the attending physician to make an evaluation decision.

Other patients who are deemed inappropriate as research subjects by the principal investigator.

No limit
No limit

Both

parkinson's disease

D010300

Confirmatory factors for the 9 domains of MDS-NMS

Genko Oyama
International Congress of Parkinsons Disease and Movement Disorders
Applicable
Research Ethics Committee, Faculty of Medicine, Juntendo University
2-1-1, Hongo, Bunkyo-ku, Tokyo, Tokyo, Tokyo

+81-3-5802-1584

crbjun@juntendo.ac.jp
Approval

May. 13, 2022

No

none

History of Changes

No Publication date
2 May. 22, 2023 (this page) Changes
1 Oct. 05, 2022 Detail